Recombinant Schizosaccharomyces pombe Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (cwp1)

What is the role of cwp1 in Schizosaccharomyces pombe?

Cwp1 (SPAPB1A10.04c) functions as the α-subunit of both geranylgeranyltransferase I (GGTase I) and farnesyltransferase (FTase) in S. pombe. These enzymes catalyze the post-translational addition of isoprenyl groups to target proteins containing specific C-terminal motifs. In S. pombe, cwp1 plays a critical role in protein prenylation pathways, affecting the localization and function of various proteins including small GTPases. Notably, cwp1 can act as a multicopy suppressor of mutations in cpp1, which encodes the β-subunit of farnesyltransferase . This functional relationship demonstrates its importance in the protein prenylation machinery of fission yeast.

How can researchers effectively express and purify recombinant cwp1 protein?

To express and purify recombinant cwp1 protein:

• Expression system selection: For functional studies, co-expression with the β-subunit (cpp1) is recommended as these proteins form a heterodimeric complex. E. coli BL21(DE3) with pET-based vectors can be used for basic structural studies, while insect cell or S. pombe expression systems are preferred for functional studies.

• Purification strategy:

  • Add a polyhistidine tag to the N-terminus of cwp1 to facilitate purification

  • Lyse cells in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT, and protease inhibitors

  • Purify using Ni-NTA affinity chromatography followed by size exclusion chromatography

  • For functional enzyme studies, co-purify with cpp1 and verify complex formation via analytical gel filtration

• Activity verification: Test enzymatic activity using fluorescent or radioactive farnesyl pyrophosphate substrates and model peptides with CAAX motifs.

What phenotypes are associated with cwp1 deletion or mutation in S. pombe?

Deletion or significant mutation of cwp1 in S. pombe results in several observable phenotypes:

• Growth defects: Cells exhibit temperature sensitivity, particularly at 36°C

• Morphological abnormalities: Cells may show irregular shape and size

• Mating defects: Decreased conjugation efficiency and sporulation

• Signaling pathway disruptions: Alterations in pathways dependent on properly farnesylated proteins

When cwp1 is overexpressed, it can suppress phenotypes associated with mutations in cpp1 (the β-subunit of farnesyltransferase), including temperature sensitivity . This suppression activity indicates the functional relationship between these subunits and suggests that increased levels of the α-subunit can compensate for reduced function of the β-subunit.

How conserved is cwp1 across different yeast species compared to S. pombe?

The α-subunit of farnesyltransferase/geranylgeranyltransferase shows significant conservation across fungal species, with particular features:

Unlike higher eukaryotes, which have separate α-subunits for FTase and GGTase I, fungi including S. pombe utilize a single α-subunit (cwp1) that functions with different β-subunits to form either enzyme complex. This evolutionary conservation pattern makes fungal prenylation systems unique research models for understanding enzyme specificity and evolution.

How does the function of cwp1 in protein farnesylation contribute to cellular responses to nutrient starvation in S. pombe?

The role of cwp1-mediated protein farnesylation in nutrient starvation responses is complex and multifaceted:

• Rhb1 regulation: Cwp1 participates in the farnesylation of Rhb1 (Rheb homolog), which is a key regulator in the TOR signaling pathway. Under normal conditions, farnesylated Rhb1 localizes to membranes and promotes TOR activity. When farnesylation is compromised (as in cpp1-1 mutants), Rhb1 becomes predominantly cytosolic, resulting in reduced TOR pathway activation .

• Nutrient sensing mechanisms: In cells lacking Tsc1 or Tsc2 (Δtsc1 or Δtsc2), which normally function as negative regulators of Rhb1, defects occur in the induction of nitrogen starvation-responsive genes. These defects can be partially suppressed by mutations that reduce protein farnesylation (such as cpp1-1) .

• Experimental approach to study this relationship:

  • Generate strains with varying combinations of cwp1, tsc1/tsc2, and rhb1 mutations

  • Monitor gene expression changes using RNA-seq or targeted qRT-PCR of starvation-responsive genes (e.g., fnx1, mei2, inv1) under different nutrient conditions

  • Track the subcellular localization of GFP-tagged Rhb1 in these mutant backgrounds

  • Measure TOR pathway activity using phospho-specific antibodies against downstream targets

How does the interaction between cwp1 and cpp1 affect the farnesylation of Rhb1 in S. pombe?

The interaction between cwp1 and cpp1 is critical for proper farnesylation of Rhb1:

• Biochemical basis: Cwp1 (α-subunit) and Cpp1 (β-subunit) form the heterodimeric farnesyltransferase enzyme. The α-subunit primarily binds the farnesyl pyrophosphate substrate, while the β-subunit recognizes the CAAX motif of target proteins. Cpp1 contains a catalytic zinc ion at its active site that is essential for enzyme function .

• Effects of cpp1 mutation: The cpp1-1 mutation affects the glycine-254 position, which corresponds to the catalytic center that coordinates the zinc ion . This mutation reduces farnesyltransferase activity, resulting in decreased farnesylation of target proteins including Rhb1.

• Consequences for Rhb1: In wild-type cells, Rhb1 exists predominantly as a faster-migrating form on SDS-PAGE due to farnesylation. In cpp1-1 mutants, a significant portion of Rhb1 appears as a slower-migrating, unmodified form, especially at restrictive temperatures . This correlates with reduced membrane association of Rhb1, as demonstrated by subcellular fractionation studies showing decreased Rhb1 in membrane fractions of cpp1-1 mutants .

• Functional impact: The farnesylation-dependent membrane localization of Rhb1 is crucial for its biological activity. Impaired farnesylation in cpp1-1 mutants results in a partial loss of Rhb1 function, which can suppress phenotypes associated with hyperactive Rhb1 (as seen in Δtsc1 or Δtsc2 strains) .

What methodologies can be used to distinguish between the farnesyltransferase and geranylgeranyltransferase activities of cwp1 in vitro?

Distinguishing between the FTase and GGTase I activities of cwp1-containing enzyme complexes requires specialized biochemical approaches:

• Reconstitution of distinct enzyme complexes:

  • Express and purify recombinant cwp1 protein

  • Separately express and purify the β-subunits: cpp1 (FTase β) and cwg1 (GGTase I β)

  • Reconstitute FTase complex (cwp1 + cpp1) and GGTase I complex (cwp1 + cwg1)

• Substrate specificity assays:

  • Prepare synthetic CAAX-box peptides representing known FTase substrates (e.g., CVIM, CVLS) and GGTase I substrates (e.g., CVLL, CCIL)

  • Set up parallel reactions with both enzyme complexes using either [³H]-farnesyl pyrophosphate or [³H]-geranylgeranyl pyrophosphate

  • Quantify incorporation of radiolabeled isoprenoids into peptide substrates

• Competition assays:

  • Use a fixed concentration of preferred substrate for each enzyme

  • Add increasing concentrations of FTase or GGTase I specific inhibitors (e.g., FTI-277 for FTase, GGTI-298 for GGTase I)

  • Plot inhibition curves to determine relative specificity

• Kinetic analysis:

  • Determine Km and kcat values for both enzyme complexes with various substrates

  • Calculate specificity constants (kcat/Km) to quantitatively compare substrate preferences

This methodological approach allows for precise differentiation between the two enzymatic activities that share the same α-subunit but differ in their β-subunit composition.

How does cwp1 overexpression affect signaling pathways regulated by Tsc1/Tsc2 in S. pombe?

Cwp1 overexpression impacts Tsc1/Tsc2-regulated signaling pathways through multiple mechanisms:

• Enhanced farnesylation activity: Overexpression of cwp1 increases the cellular capacity for protein farnesylation, particularly when the β-subunit (cpp1) is partially compromised. This was demonstrated by the ability of cwp1 overexpression to suppress the temperature sensitivity of cpp1-1 mutants .

• Rhb1 activation: Increased farnesylation promotes membrane localization of Rhb1, enhancing its ability to activate the TOR pathway. In cells lacking Tsc1/Tsc2 (negative regulators of Rhb1), cwp1 overexpression may exacerbate the hyperactive Rhb1 phenotype, leading to:

  • Further dysregulation of nutrient-responsive gene expression

  • Enhanced resistance to canavanine (toxic arginine analog)

  • Exacerbated defects in amino acid uptake

• Experimental assessment approaches:

  • Construct strains with cwp1 under the control of an inducible promoter (e.g., nmt1)

  • Compare phenotypes of wild-type, Δtsc1, Δtsc2, and cpp1-1 strains with or without cwp1 overexpression

  • Monitor membrane association of Rhb1 using subcellular fractionation

  • Assess TOR pathway activation using phosphorylation status of downstream targets

  • Measure expression of nutrient-responsive genes (fnx1, mei2, inv1) under different conditions

• Phenotypic readouts for pathway activity:

  • Growth on media containing limited leucine (40 μg/ml)

  • Resistance to canavanine

  • Induction of nitrogen starvation-responsive genes

  • Temperature sensitivity

What techniques can be used to identify novel protein substrates of cwp1-containing farnesyltransferase complexes?

Identification of novel farnesyltransferase substrates requires a multi-faceted approach:

• Bioinformatic screening:

  • Perform genome-wide analysis of S. pombe proteins containing C-terminal CAAX motifs (typically C is cysteine, A is an aliphatic amino acid, and X determines specificity for FTase vs. GGTase I)

  • Prioritize candidates based on subcellular localization patterns and functional annotations

  • Compare with known farnesylated proteins in related species

• Chemical biology approaches:

  • Metabolic labeling with alkyne-modified farnesyl analogs (e.g., alkyne-FPP)

  • Cell lysis and click chemistry-based conjugation of biotin-azide

  • Streptavidin pulldown and mass spectrometry analysis

  • Comparison between wild-type, cpp1-1, and cwp1-overexpressing strains

• Genetic interaction screening:

  • Perform synthetic genetic array (SGA) analysis with cpp1-1 or cwp1 overexpression

  • Identify genetic interactions that suggest functional relationships

  • Validate potential substrates through direct farnesylation assays

• Mobility shift assays:

  • Test candidate proteins by western blot analysis in wild-type vs. cpp1-1 strains

  • Look for mobility differences indicative of prenylation status (as demonstrated with Rhb1)

  • Confirm by analyzing membrane association through subcellular fractionation

• In vitro farnesylation assays:

  • Express recombinant candidate proteins with intact C-termini

  • Incubate with purified cwp1-cpp1 complex and [³H]-farnesyl pyrophosphate

  • Analyze incorporation of radioactivity to confirm direct farnesylation

What are the critical parameters for designing experiments to study cwp1 function in vivo?

When designing experiments to study cwp1 function in vivo, researchers should consider:

• Temperature conditions: The cpp1-1 mutation causes temperature sensitivity, with more pronounced effects at 36°C . Design experiments with appropriate temperature controls and consider temperature shift experiments to acutely disrupt farnesylation.

• Growth media composition: Nutrient availability significantly affects pathways regulated by farnesylated proteins. Consider:

  • Minimal media with defined amino acid concentrations

  • Nitrogen starvation conditions to assess starvation responses

  • Inclusion of canavanine as a phenotypic readout for arginine permease function

• Strain construction strategies:

  • Use genomic integration of tags rather than plasmid-based expression when possible

  • Consider the position of tags (N-terminal vs. C-terminal) as C-terminal tags may interfere with CAAX-box recognition

  • When making deletion strains, verify that neighboring genes are unaffected

• Expression level control:

  • For complementation or overexpression studies, use a range of promoters with different strengths (e.g., nmt1, nmt41, nmt81)

  • Consider inducible systems to distinguish between acute and chronic effects of altered cwp1 activity

• Phenotypic readouts:

  • Growth assays under various conditions

  • Gene expression analysis of known target genes (fnx1, mei2, inv1)

  • Membrane association of farnesylated proteins

  • Nitrogen starvation response

How can researchers address experimental challenges when studying the interaction between cwp1 and its binding partners?

Common challenges and their solutions when studying cwp1 interactions include:

• Challenge: Distinguishing direct from indirect interactions
  Solution:

  • Implement yeast two-hybrid assays with appropriate controls

  • Perform in vitro binding assays with purified components

  • Use proximity labeling techniques (BioID, APEX) to identify proteins in close proximity to cwp1 in vivo

• Challenge: Maintaining enzymatic activity during purification
  Solution:

  • Co-express α and β subunits to promote complex stability

  • Include zinc in purification buffers to maintain the integrity of the catalytic site

  • Use mild detergents when working with membrane-associated complexes

  • Optimize buffer conditions (pH, salt concentration) based on activity assays

• Challenge: Assessing complex formation in vivo
  Solution:

  • Implement bimolecular fluorescence complementation (BiFC)

  • Use split-luciferase assays for quantitative analysis

  • Perform co-immunoprecipitation under native conditions

  • Consider chemical crosslinking to capture transient interactions

• Challenge: Distinguishing between FTase and GGTase I activities
  Solution:

  • Use specific inhibitors to selectively block each activity

  • Employ substrate peptides with varying CAAX sequences

  • Analyze protein prenylation in strains with mutations in specific β-subunits

• Challenge: Identifying relevant physiological substrates
  Solution:

  • Combine bioinformatic predictions with experimental validation

  • Implement proteomics approaches to identify differentially modified proteins

  • Use genetic suppressor screens to identify functional relationships

How should researchers interpret contradictory results when studying cwp1 function?

When faced with contradictory results in cwp1 research, consider the following analytical approach:

• Experimental context differences:

  • Strain background variations: Different S. pombe strains may have genetic modifiers affecting cwp1 function

  • Growth conditions: Temperature, media composition, and growth phase significantly impact prenylation pathways

  • Expression level variations: Overexpression vs. endogenous expression can lead to different outcomes

• Technical considerations:

  • Protein tagging effects: Tags may interfere with protein interactions or enzymatic activity

  • Assay sensitivity limits: Some methods may not detect subtle changes in farnesylation

  • Sample preparation variations: Membrane protein extraction efficiency can vary between protocols

• Specific contradictions and solutions:

  • If membrane localization and biochemical farnesylation assays give conflicting results, consider that other modifications may affect localization

  • If genetic interaction data conflicts with biochemical data, consider indirect effects or compensatory mechanisms

  • If overexpression phenotypes contradict deletion phenotypes, analyze dose-dependency with titrated expression levels

• Integrative analysis approach:

  • Synthesize data from multiple experimental approaches

  • Weigh evidence based on methodological rigor

  • Consider models that accommodate seemingly contradictory observations

  • Design decisive experiments to directly test competing hypotheses

What statistical approaches are most appropriate for analyzing data from experiments involving cwp1?

When analyzing data from cwp1 experiments, consider these statistical approaches:

What are the most promising approaches for advancing our understanding of cwp1 function in cell signaling?

Future research on cwp1 function in cell signaling should focus on:

• Integrated multi-omics approaches:

  • Combine proteomics, transcriptomics, and metabolomics to comprehensively map the effects of cwp1 activity on cellular networks

  • Implement phospho-proteomics to understand how farnesylation interfaces with other post-translational modifications

  • Use metabolic labeling strategies to track the dynamics of protein prenylation under different conditions

• Structural biology advancements:

  • Determine high-resolution structures of S. pombe cwp1-cpp1 and cwp1-cwg1 complexes

  • Use cryo-EM to visualize substrate binding and catalytic mechanisms

  • Employ hydrogen-deuterium exchange mass spectrometry to map dynamic interactions

  • Design structure-guided mutations to dissect specificity determinants

• Systems-level genetic analysis:

  • Implement genome-wide CRISPR screens in cwp1 mutant backgrounds

  • Create comprehensive genetic interaction maps centered on protein prenylation pathways

  • Develop conditional alleles to study essential functions

  • Use synthetic genetic array analysis to identify functional relationships

• Investigation of regulatory mechanisms:

  • Characterize transcriptional and post-translational regulation of cwp1

  • Identify factors that influence substrate selection by cwp1-containing enzymes

  • Explore potential feedback mechanisms between farnesylation and other cellular processes

  • Study temporal dynamics of cwp1 activity throughout the cell cycle and in response to stresses

• Therapeutic relevance exploration:

  • Compare mechanisms of farnesyltransferase inhibition between fungal and human enzymes

  • Identify unique features of fungal prenylation that could be exploited for antifungal development

  • Study the role of cwp1-mediated farnesylation in cellular stress responses and adaptation

How might advances in genome editing and high-throughput screening techniques enhance cwp1 research?

Modern genomic technologies offer significant opportunities for advancing cwp1 research:

• CRISPR-Cas9 applications:

  • Generate precise point mutations to study structure-function relationships

  • Create conditional alleles using auxin-inducible degrons or other rapid depletion systems

  • Implement base editing to introduce specific CAAX box modifications in potential substrates

  • Develop pooled CRISPR screens to identify genetic interactions with cwp1

• High-throughput phenotypic screening:

  • Design reporter systems for farnesylation activity

  • Implement automated microscopy to analyze protein localization changes

  • Develop growth-based screens with varied conditions to identify condition-specific functions

  • Use barcode-based pooled screening to assess genetic interactions at scale

• Single-cell approaches:

  • Apply single-cell RNA-seq to identify cell-to-cell variation in responses to cwp1 perturbation

  • Implement microfluidics to study dynamic responses at the single-cell level

  • Use flow cytometry with fluorescent reporters to quantify pathway activities

  • Develop cell-specific cwp1 manipulation strategies to study tissue context effects

• Integrative multi-omics:

  • Combine CRISPR screening with proteomics to identify functional prenylation targets

  • Implement parallel genetic and chemical genetic approaches

  • Develop computational frameworks to integrate diverse data types

  • Use machine learning to predict prenylation sites and functional consequences

• Synthetic biology approaches:

  • Engineer synthetic cwp1 variants with altered specificity

  • Create orthogonal prenylation systems for specific substrate targeting

  • Develop biosensors for real-time monitoring of prenylation activity

  • Design genetic circuits to probe the functional consequences of farnesylation dynamics